About
Technology
Issues
FAQ
Links
Official Page
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.